Abacavir sulfate is a potent HIV-specific agent commonly prescribed in ASCOMYCIN 11011-38-4 the management of human immunodeficiency virus (HIV) infection. It exerts its action by competitively inhibiting the activity of the viral reverse transcriptase enzyme, thereby hampering the conversion of HIV RNA to DNA. This interference disrupts the prolif